Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis

Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis

Abstract Background The aim of this study was to evaluate the efficacy and safety of osimertinib for the treatment of leptomeningeal metastases (LM) from epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Methods We conducted a systematic review and meta-analysis to a...

Full description

Bibliographic Details
Main Authors: Lei Wen, Junjie Zhen, Changguo Shan, Mingyao Lai, Weiping Hong, Hui Wang, Mingting Ye, Yanying Yang, Shaoqun Li, Zhaoming Zhou, Jiangfen Zhou, Qingjun Hu, Juan Li, Xuwei Tian, Longhua Chen, Linbo Cai, Zhanhong Xie, Cheng Zhou
Format: Article
Language:English
Published: BMC 2023-08-01
Series:European Journal of Medical Research
Subjects:
Osimertinib
EGFR
NSCLC
Leptomeningeal metastases (LM)
Efficacy
Meta-analysis
Online Access:https://doi.org/10.1186/s40001-023-01219-y

Internet

https://doi.org/10.1186/s40001-023-01219-y

Similar Items